UBS analyst Dan Leonard raised the firm’s price target on Thermo Fisher (TMO) to $500 from $460 and keeps a Neutral rating on the shares. Thermo Fisher reported a Q2 beat with “responsible” forward framing, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
